Clinical Trial Update: Fexofenadine Use in Gastroesophageal Reflux Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fexofenadine for gastroesophageal reflux symptoms was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Fexofenadine (fexofenadine)

Snippet

Sponsor: Stanford University | Conditions: Gastroesophageal Reflux | Phase 2 | Status: TERMINATED | Results posted: 2021-02-17